Evaluating the effects of preanalytical variables on the stability of the human plasma proteome

Analytical Biochemistry

Volumn 478, Issue , 2015, Pages 14-22

  Hassis, Maria E ^a,b   Niles, Richard K ^a,b   Braten, Miles N ^a,b   Albertolle, Matthew E ^a,b   Ewa Witkowska, H ^a,b   Hubel, Carl A ^c   Fisher, Susan J ^a,b   Williams, Katherine E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Mass spectrometry; Plasma; Preanalytical variables; Proteomics; Serum

Indexed keywords

BIOMARKERS; BLOOD; MASS SPECTROMETRY; PLASMAS; PROTEINS; PROTEOMICS;

BIO-MARKER DISCOVERY; FREEZE-THAW CYCLES; PREANALYTICAL VARIABLES; PROCESSING TIME; PROCESSING VARIABLES; PROTEIN STRUCTURES; PROTEOLYTIC DEGRADATION; SERUM;

PLASMA STABILITY;

BIOLOGICAL MARKER; PROTEOME; PLASMA PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CENTRIFUGATION; FEMALE; FREEZE THAWING; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; QUALITY CONTROL; RELIABILITY; FREEZING; PROTEOMICS; SPECIMEN HANDLING;

BLOOD PROTEINS; CENTRIFUGATION; CHROMATOGRAPHY, LIQUID; FREEZING; HUMANS; PROTEIN STABILITY; PROTEOME; PROTEOMICS; SPECIMEN HANDLING;

EID: 84961344094     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2015.03.003     Document Type: Article

References (47)

1. N.L. Anderson, and N.G. Anderson The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 1 2002 845 867
2. G.L. Hortin, and D. Sviridov The dynamic range problem in the analysis of the plasma proteome J. Proteomics 73 2010 629 636
3. A. Hakimi, J. Auluck, G.D. Jones, L.L. Ng, and D.J. Jones Assessment of reproducibility in depletion and enrichment workflows for plasma proteomics using label-free quantitative data-independent LC-MS Proteomics 14 2014 4 13
4. S.E. Abbatiello, D.R. Mani, B. Schilling, B. Maclean, L.J. Zimmerman, X. Feng, M.P. Cusack, N. Sedransk, S.C. Hall, T. Addona, S. Allen, N.G. Dodder, M. Ghosh, J.M. Held, V. Hedrick, H.D. Inerowicz, A. Jackson, H. Keshishian, J.W. Kim, J.S. Lyssand, C.P. Riley, P. Rudnick, P. Sadowski, K. Shaddox, D. Smith, D. Tomazela, A. Wahlander, S. Waldemarson, C.A. Whitwell, J. You, S. Zhang, C.R. Kinsinger, M. Mesri, H. Rodriguez, C.H. Borchers, C. Buck, S.J. Fisher, B.W. Gibson, D. Liebler, M. Maccoss, T.A. Neubert, A. Paulovich, F. Regnier, S.J. Skates, P. Tempst, M. Wang, and S.A. Carr Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS) Mol. Cell. Proteomics 12 2013 2623 2639
5. H.J. Issaq, T.J. Waybright, and T.D. Veenstra Cancer biomarker discovery: opportunities and pitfalls in analytical methods Electrophoresis 32 2011 967 975
6. S.J. Skates, M.A. Gillette, J. LaBaer, S.A. Carr, L. Anderson, D.C. Liebler, D. Ransohoff, N. Rifai, M. Kondratovich, Z. Tezak, E. Mansfield, A.L. Oberg, I. Wright, G. Barnes, M. Gail, M. Mesri, C.R. Kinsinger, H. Rodriguez, and E.S. Boja Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies J. Proteome Res. 12 2013 5383 5394
7. D.F. Ransohoff How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design J. Clin. Epidemiol. 60 2007 1205 1219
8. H.M. Moore, A. Kelly, S.D. Jewell, L.M. McShane, D.P. Clark, R. Greenspan, P. Hainaut, D.F. Hayes, P. Kim, E. Mansfield, O. Potapova, P. Riegman, Y. Rubinstein, E. Seijo, S. Somiari, P. Watson, H.U. Weier, C. Zhu, and J. Vaught Biospecimen reporting for improved study quality Biopreserv. Biobank. 9 2011 57 70
9. A.J. Rai, C.A. Gelfand, B.C. Haywood, D.J. Warunek, J. Yi, M.D. Schuchard, R.J. Mehigh, S.L. Cockrill, G.B. Scott, H. Tammen, P. Schulz-Knappe, D.W. Speicher, F. Vitzthum, B.B. Haab, G. Siest, and D.W. Chan HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples Proteomics 5 2005 3262 3277
10. S.D. Jewell, M. Srinivasan, L.M. McCart, N. Williams, W.H. Grizzle, V. LiVolsi, G. MacLennan, and D.D. Sedmak Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network Am. J. Clin. Pathol. 118 2002 733 741
11. M.K. Tuck, D.W. Chan, D. Chia, A.K. Godwin, W.E. Grizzle, K.E. Krueger, W. Rom, M. Sanda, L. Sorbara, S. Stass, W. Wang, and D.E. Brenner Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group J. Proteome Res. 8 2009 113 117
12. A.M. Zawadzka, B. Schilling, M.P. Cusack, A.K. Sahu, P. Drake, S.J. Fisher, C.C. Benz, and B.W. Gibson Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma Mol. Cell. Proteomics 13 2014 1034 1049
13. J. Yi, C. Kim, and C.A. Gelfand Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma J. Proteome Res. 6 2007 1768 1781
14. L.J. Zimmerman, M. Li, W.G. Yarbrough, R.J. Slebos, and D.C. Liebler Global stability of plasma proteomes for mass spectrometry-based analyses Mol. Cell. Proteomics 11 2012 M111 014340
15. S.A. Randall, M.J. McKay, M.S. Baker, and M.P. Molloy Evaluation of blood collection tubes using selected reaction monitoring MS: implications for proteomic biomarker studies Proteomics 10 2010 2050 2056
16. A. Aguilar-Mahecha, M.A. Kuzyk, D. Domanski, C.H. Borchers, and M. Basik The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines PLoS One 7 2012 e38290
17. J. Marshall, P. Kupchak, W. Zhu, J. Yantha, T. Vrees, S. Furesz, K. Jacks, C. Smith, I. Kireeva, R. Zhang, M. Takahashi, E. Stanton, and G. Jackowski Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction J. Proteome Res. 2 2003 361 372
18. M. Insenser, M. Martinez-Garcia, R.M. Nieto, J.L. San-Millan, and H.F. Escobar-Morreale Impact of the storage temperature on human plasma proteomic analysis: implications for the use of human plasma collections in research Proteomics Clin. Appl. 4 2010 739 744
19. H.J. Issaq, Z. Xiao, and T.D. Veenstra Serum and plasma proteomics Chem. Rev. 107 2007 3601 3620
20. T.A. Addona, S.E. Abbatiello, B. Schilling, S.J. Skates, D.R. Mani, D.M. Bunk, C.H. Spiegelman, L.J. Zimmerman, A.J. Ham, H. Keshishian, S.C. Hall, S. Allen, R.K. Blackman, C.H. Borchers, C. Buck, H.L. Cardasis, M.P. Cusack, N.G. Dodder, B.W. Gibson, J.M. Held, T. Hiltke, A. Jackson, E.B. Johansen, C.R. Kinsinger, J. Li, M. Mesri, T.A. Neubert, R.K. Niles, T.C. Pulsipher, D. Ransohoff, H. Rodriguez, P.A. Rudnick, D. Smith, D.L. Tabb, T.J. Tegeler, A.M. Variyath, L.J. Vega-Montoto, A. Wahlander, S. Waldemarson, M. Wang, J.R. Whiteaker, L. Zhao, N.L. Anderson, S.J. Fisher, D.C. Liebler, A.G. Paulovich, F.E. Regnier, P. Tempst, and S.A. Carr Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 27 2009 633 641
21. R.C. Dwivedi, V. Spicer, M. Harder, M. Antonovici, W. Ens, K.G. Standing, J.A. Wilkins, and O.V. Krokhin Practical implementation of 2D HPLC scheme with accurate peptide retention prediction in both dimensions for high-throughput bottom-up proteomics Anal. Chem. 80 2008 7036 7042
22. V. Tambor, C.L. Hunter, S.L. Seymour, M. Kacerovsky, J. Stulik, and J. Lenco CysTRAQ - a combination of iTRAQ and enrichment of cysteinyl peptides for uncovering and quantifying hidden proteomes J. Proteomics 2011
23. A.K. Yadav, G. Bhardwaj, T. Basak, D. Kumar, S. Ahmad, R. Priyadarshini, A.K. Singh, D. Dash, and S. Sengupta A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery PLoS One 6 2011 e24442
24. C. Tu, P.A. Rudnick, M.Y. Martinez, K.L. Cheek, S.E. Stein, R.J. Slebos, and D.C. Liebler Depletion of abundant plasma proteins and limitations of plasma proteomics J. Proteome Res. 9 2010 4982 4991
25. C.M. Shuford, A.M. Hawkridge, J.C. Burnett Jr., and D.C. Muddiman Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma Anal. Chem. 82 2010 10179 10185
26. T. Liu, W.J. Qian, H.M. Mottaz, M.A. Gritsenko, A.D. Norbeck, R.J. Moore, S.O. Purvine, D.G. Camp 2nd, and R.D. Smith Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry Mol. Cell. Proteomics 5 2006 2167 2174
27. R.L. Gundry, Q. Fu, C.A. Jelinek, J.E. Van Eyk, and R.J. Cotter Investigation of an albumin-enriched fraction of human serum and its albuminome Proteomics Clin. Appl. 1 2007 73 88
28. S. Schenk, G.J. Schoenhals, G. de Souza, and M. Mann A high confidence, manually validated human blood plasma protein reference set BMC Med. Genomics 1 2008 41
29. D.A. Prieto, D.J. Johann Jr., B.R. Wei, X. Ye, K.C. Chan, D.V. Nissley, R.M. Simpson, D.E. Citrin, C.L. Mackall, W.M. Linehan, and J. Blonder Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens Biomarkers Med. 8 2014 269 286
30. L. Baczynskyj, G.E. Bronson, and T.M. Kubiak Application of thermally assisted electrospray ionization mass spectrometry for detection of noncovalent complexes of bovine serum albumin with growth hormone releasing factor and other biologically active peptides Rapid Commun. Mass Spectrom. 8 1994 280 286
31. W.A. Carter Binding of human interferons to immobilized albumin Methods Enzymol. 78 1981 576 582
32. U. Sjobring, L. Bjorck, and W. Kastern Streptococcal protein G. Gene structure and protein binding properties J. Biol. Chem. 266 1991 399 405
33. D.C. Carter, and J.X. Ho Structure of serum albumin Adv. Protein Chem. 45 1994 153 203
34. T. Peters Jr. Serum albumin Adv. Protein Chem. 37 1985 161 245
35. G. Colombo, M. Clerici, D. Giustarini, R. Rossi, A. Milzani, and I. Dalle-Donne Redox Albuminomics: Oxidized Albumin in Human Diseases 2012 Antioxid Redox Signal
36. T. Farrah, E.W. Deutsch, G.S. Omenn, D.S. Campbell, Z. Sun, J.A. Bletz, P. Mallick, J.E. Katz, J. Malmstrom, R. Ossola, J.D. Watts, B. Lin, H. Zhang, R.L. Moritz, and R. Aebersold A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas Mol. Cell. Proteomics 10 2011 M110.006353
37. H.K. Hustoft, H. Malerod, S.R. Wilson, L. Reubsaet, E. Lundanes, and T. Greibrokk A critical review of trypsin digestion for LC-MS based proteomics H.-C. Leung, Integrative Proteomics 2012 InTech http://www.intechopen.com/books/integrative-proteomics
38. B.L. Mitchell, Y. Yasui, C.I. Li, A.L. Fitzpatrick, and P.D. Lampe Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects Cancer Inform. 1 2005 98 104
39. J. Villanueva, J. Philip, C.A. Chaparro, Y. Li, R. Toledo-Crow, L. DeNoyer, M. Fleisher, R.J. Robbins, and P. Tempst Correcting common errors in identifying cancer-specific serum peptide signatures J Proteome Res. 4 2005 1060 1072
40. B.B. Haab, B.H. Geierstanger, G. Michailidis, F. Vitzthum, S. Forrester, R. Okon, P. Saviranta, A. Brinker, M. Sorette, L. Perlee, S. Suresh, G. Drwal, J.N. Adkins, and G.S. Omenn Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data Proteomics 5 2005 3278 3291
41. G.L. Hortin, D. Sviridov, and N.L. Anderson High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance Clin. Chem. 54 2008 1608 1616
42. M. Polanski, and N.L. Anderson A list of candidate cancer biomarkers for targeted proteomics Biomarker Insights 1 2007 1 48
43. M.A. Gillette, and S.A. Carr Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry Nat. Methods 10 2013 28 34
44. L.D. Campbell, F. Betsou, D.L. Garcia, J.G. Giri, K.E. Pitt, R.S. Pugh, K.C. Sexton, A.P. Skubitz, and S.B. Somiari Development of the ISBER best practices for repositories: collection, storage, retrieval and distribution of biological materials for research Biopreserv. Biobank. 10 2012 232 233
45. J.A. Robb, M.L. Gulley, P.L. Fitzgibbons, M.F. Kennedy, L.M. Cosentino, K. Washington, R.C. Dash, P.A. Branton, S.D. Jewell, and R.L. Lapham A call to standardize preanalytic data elements for biospecimens Arch. Pathol. Lab. Med. 138 2014 526 537
46. F. Betsou, E. Gunter, J. Clements, Y. DeSouza, K.A. Goddard, F. Guadagni, W. Yan, A. Skubitz, S. Somiari, T. Yeadon, and R. Chuaqui Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group J. Mol. Diagn. 15 2013 3 16
47. K.B. Engel, J. Vaught, and H.M. Moore National Cancer Institute Biospecimen Evidence-Based Practices: a novel approach to pre-analytical standardization Biopreserv. Biobank. 12 2014 148 150